Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 1.30M | $43.0M | 7.87% | +589.5K | 2026-06-30 |
| BVF INC/IL | 1.25M | $41.0M | 7.55% | -- | 2026-06-30 |
| BlackRock, Inc. | 1.12M | $37.0M | 6.77% | +890.0K | 2026-06-30 |
| SAMSARA BIOCAPITAL, LLC | 1.06M | $35.0M | 6.41% | -- | 2026-06-30 |
| Kynam Capital Management, LP | 872.6K | $28.0M | 5.26% | -- | 2026-06-30 |
| ORBIMED ADVISORS LLC | 743.9K | $24.0M | 4.49% | -57.2K | 2026-06-30 |
| Balyasny Asset Management L.P. | 711.2K | $23.0M | 4.29% | +245.4K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 694.2K | $23.0M | 4.19% | -26.2K | 2026-06-30 |
| EVENTIDE ASSET MANAGEMENT, LLC | 585.3K | $19.0M | 3.53% | -130.0K | 2026-06-30 |
| Velan Capital Investment Management LP | 512.2K | $17.0M | 3.09% | -- | 2026-06-30 |
